Influence of homocysteine on fibrin network lysis

Blood Coagulation and Fibrinolysis

Volumn 17, Issue 3, 2006, Pages 181-186

  Lauricella, Ana María ^a   Quintana, Irene ^a   Castañon, Mercedes ^a   Sassetti, Beatriz ^a   Kordich, Lucía ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Fibrin networks; Fibrinolysis; Homocysteine

Indexed keywords

FIBRIN; HOMOCYSTEINE; PLASMINOGEN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

AMINO ACID ANALYSIS; ARTICLE; BINDING KINETICS; CONTROLLED STUDY; ELECTRON MICROSCOPY; FIBER; FIBRIN METABOLISM; GENETIC RESISTANCE; HUMAN; HUMAN CELL; HYPERHOMOCYSTEINEMIA; LYSIS; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; REGULATORY MECHANISM; THICKNESS; VASCULAR DISEASE;

BLOOD COAGULATION; FIBRIN; FIBRINOLYSIS; HOMOCYSTEINE; HUMANS; MICROSCOPY, ELECTRON; PLASMA; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATORS; PLASMINOGEN INACTIVATORS;

EID: 33645533315     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000220238.99843.45     Document Type: Article

References (31)

1. Bertina RM. Molecular risk factor for thrombosis. Thromb Haemost 1999; 82:601-609.
2. Guba S, Fonseca V, Fink L. Hyperhomocysteinemia and thrombosis. Semin Thromb Hemost 1999; 25:291-309.
3. D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood 1997; 90:1-11.
4. Van Guldener C, Stehouwer C. Hyperhomocysteinemia, vascular pathology and endothelial dysfunction. Semin Thromb Hemost 2000; 26:313-324.
5. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998; 338:1042-1050.
6. Mujumdar V, Aru G, Tgagi S. Induction of oxidative stress by homocyst(e)ine impairs endothelial function. J Cell Biochem 2001; 82:491-500.
7. Coppola A, Giovanni D, De Stefano V, Mancini F, Cerbone A, Di Minno G. Homocysteine, coagulation, platelet function, and thrombosis. Semin Thromb Hemost 2000; 26:243-254.
8. Ueland M. Homocysteine species as components of plasma redox thiol status. Clin Chem 1995; 41:340-342.
9. Lauricella AM, Quintana I, Kordich L. Effects of homocysteine thiol group on fibrin networks: another possible mechanism of harm. Thromb Res 2002; 107:75-79.
10. Sauls DL, Wolberg AS, Hoffman M. Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia. J Thromb Haemost 2003; 1:300-306.
11. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project. JAMA 1997; 277:1775-1781.
12. Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, et al. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr 2000; 71:962-968.
13. Miller JW. Homocysteine and Alzheimer's disease. Nutr Rev 1999; 57:126-129.
14. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk for vascular disease: probable benefits of increasing folic acid intake. JAMA 1995; 274:1049-1057.
15. Clarke R, Armitage J. Vitamin supplements and cardiovascular risk: review of the randomised trials and homocysteine-lowering vitamin supplements. Semin Thromb Hemost 2000; 26:341-348.
16. Smilde T, van den Berkmortel F, Boerts GH, Wollersheim H, de Boo T, van Langen, et al. Carotid and femoral artery wall thickness in patients at risk for cardiovascular disease, with emphasis on hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 1998; 18:1958-1963.
17. Lambert J, van der Berg M, Steyn M, Rauwerda JA, Donker AJ, Stehouwer CD, et al. Familial hyperhomocysteinaemia and endothelium-dependent vasodilation and arterial distensibility of large arteries. Cardiovasc Res 1999; 42:743-751.
18. Poddar R, Sivasubramanian N, Di Bello PM, Robinson K, Jacobsen DW. Homocysteine induces expression and secretion of monocyte chemottractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation 2001; 103:2717-2723.
19. Weiss N. Mechanisms of increased vascular oxidant stress in hiperhomocysteinemia and its impact on endothelial function. Curr Drug Metab 2005; 6:27-36.
20. Weisel J, Veklich Y, Collet J, Francis C. Structural studies of fibrinolysis by electron and light microscopy. Thromb Haemost 1999; 82:277-282.
21. Meh DA, Mosesson MW, DiOrio JP, Siebenlist KR, Hernandez I, Amrani DL, Stojanovich L. Desintegration and reorganization of fibrin networks during tissue-type plaminogen activator-induced clot lysis. Blood Coagul Fibrinolysis 2001; 12:627-637.
22. Collet JP, Park D, Lesty C, Soria J, Soria C, Montalescot G, et al. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed. Dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol 2000; 20:1354-1361.
23. Wu JH, Siddiqui K, Diamond S. Transport phenomena and clot dissolving therapy: an experimental investigation of diffusion-controlled and permeation-enheanced fibrinolysis. Thromb Haemost 1994; 72:105-112.
24. Kolev K, Machovich R. Molecular and cellular modulation of fibrinolysis. Thromb Haemost 2003; 89:610-621.
25. Carr ME, Alving BM. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots. Blood Coagul Fibrinolysis 1995; 6:567-573.
26. Gabriel DA, Muga K, Boothroyd EM. The effect of fibrin structure in fibrinolysis. J Biol Chem 1992; 267:24259-24263.
27. Collet JP, Nagaswami C, Farrell DH, Montalescot G, Weisel JW. Influence of gamma' fibrinogen splice variant on fibrin physical properties and fibrinolysis rate. Arterioscler Thromb Vasc Biol 2004; 24:382-386.
28. Siebenlist KR, Mosesson MW, Hernandez I, Bush LA, Di Cera E, Shainoff JR, et al. Studies on the basis for the properties of fibrin produced from fibrinogen containing gamma' chains. Blood 2005; 106:2730-2736.
29. Siebenlist K, Meh D, Mosesson M. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin. Thromb Haemost 2001; 86:1221-1228.
30. Tofler GH, D'Agostino RB, Jacques PF, Bostom AG, Wilson PWF, Lipinska I, et al. Association between increased homocysteine levels and impaired fibrinolytic potencial: potencial mechanism for cardiovascular risk. Thromb Haemost 2002; 88:799-804.
31. Hajjar KA. Homocysteine induced modulation of tissue of plasminogen activator binding to its endothelial cell membrane receptor. J Clin Invest 1993; 91:2873-2879.